{"schema_version":"secwatch.filing_event.v1","accession":"0000885978-26-000042","form_type":"8-K","ticker":"USPH","cik":"0000885978","company_name":"U S PHYSICAL THERAPY INC /NV","filed_at":"2026-08-06T20:10:10+00:00","discovered_at":"2026-08-06T20:11:31.330108+00:00","generated_at":"2026-08-06T20:13:32.785509+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"USPH Q2 GAAP EPS falls to $0.25 from $0.58; revenue up 8.5%; reaffirms FY guidance","bullets":["Q2 2026 net revenue $214.1M (+8.5% YoY); GAAP EPS $0.25 vs $0.58; adjusted EBITDA $27.0M vs $26.9M.","Physical therapy net revenue $182.4M (+8.4%); visits up 6.6%; net revenue per visit $107.59 (+$2.26).","Board declared $0.46 quarterly dividend, payable Sept 11, 2026 to holders of record Aug 21.","Three 2026 acquisitions totaling $37.6M; July 1 added 12 clinics for $16.4M.","Full-year 2026 adjusted EBITDA guidance reaffirmed at $102M-$106M."],"urls":{"canonical":"https://secwatch.observer/filing/0000885978-26-000042","json":"https://secwatch.observer/filing/0000885978-26-000042.json","markdown":"https://secwatch.observer/filing/0000885978-26-000042.md","text":"https://secwatch.observer/filing/0000885978-26-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885978/000088597826000042/0000885978-26-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885978/000088597826000042/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T20:13:32.785509+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}